For FY2027, Sono-Tek Reiterated Its Prior Guidance For Flat To Modest Revenue Growth Reflecting The Timing Of Several Large Orders, Growing Demand In The Medical Device Market, And Higher Value Production Systems

Steve Harshbarger, President and Chief Executive Officer of Sono-Tek, stated, "Fiscal 2027 is progressing well, with solid first-half revenue growth, meaningful gross margin expansion and strong improvement in operating profitability. These results reflect disciplined execution across our operations and continued progress with our strategy of focusing on higher-value production systems in advanced technology markets, particularly medical devices. Medical was again the primary growth driver, with first-half sales increasing 289%, led by strong demand for balloon coating and specialty stent-coating systems. We are particularly encouraged by the increasing adoption of our technology as customers move from development into commercial manufacturing."